U.S., Aug. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07099989) titled 'Pharmacokinetics of GATE-251 in Fasted or Fed State' on July 21.
Brief Summary: The primary purpose of this study is to assess the effect of food on the rate and extent of absorption of a single dose of GATE-251 3 mg or 10 mg oral tablets tablets in healthy adult volunteers.
Study Start Date: July 24
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers in Fed and Fasted State
Intervention:
DRUG: Zelquistinel 3 mg
Subjects will receive Zelquistinel 3 mg in fed and fasted state (high fat meal).
DRUG: Zelquistinel 10 mg
Subjects will receive Zelquistinel 10 mg in fed and fasted state (high fat meal).
Recruitment Status: RE...